About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Researchers Question Efficiency of Whooping Cough Vaccine

by Kathy Jones on September 13, 2012 at 9:28 PM
Font : A-A+

 Researchers Question Efficiency of Whooping Cough Vaccine

Researchers in the US are questioning the method through which the United States protects her citizens against whooping cough. The latter is a disease that has killed 11 babies and sickened thousands of people in a major outbreak in 2010.

The current vaccine known as DTaP, which is designed to protect against whooping cough but also tetanus and diphtheria, wanes greatly in efficiency in the five years following the fifth shot given to children as per recommendations from the Centers for Disease control, the study said.

Advertisement

It was carried out in California by the Kaiser Permanente Vaccine Study Center and published in the online version of the New England Journal of Medicine.

The study period included a major whooping cough outbreak in California in 2010. It killed 11 newborns and more than 8,000 people fell ill. The disease is also known as pertussis.
Advertisement

In the United States, the CDC recommends children get five shots, starting at two months and with the last coming between the ages of four and six, right before they start school.

The research was the first to focus specifically on a large population of highly vaccinated children who had exclusively received DTaP vaccines since birth and for whom enough time had passed since their fifth dose that the vaccine waning could be assessed.

"The findings suggest that whooping cough control measures may need to be reconsidered. Prevention of future outbreaks may be best achieved by developing new pertussis-containing vaccines or reformulating current vaccines to provide long-lasting immunity," said Nicola Klein, lead author of the study.

In the study, researchers compared 277 children, aged four to 12 and who were positive for whooping cough, with 3,318 children who were negative for pertussis and separately with 6,086 matched controls.

They assessed the risk of pertussis in children from 2006 to 2011 in California relative to the time since the fifth dose of DTaP. The researchers found that protection from pertussis after the fifth dose of DTaP vaccine wanes more than 40 percent each year.

The amount of protection remaining after five years depends heavily on the initial effectiveness of the fifth dose of DTaP, according to Klein.

Source: AFP
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Are Menopause Symptoms Troubling You?: Try these Options
Vaccination  And Counter  Measures Against  Monkeypox
Indian Railways Special Concession on Health Grounds
View all
Recommended Reading
News Archive
Date
Category
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Flu Whooping Cough Vaccination for Children Cough Symptom Evaluation Coughing up Blood Symptom Evaluation 

Most Popular on Medindia

Diaphragmatic Hernia Blood - Sugar Chart Blood Donation - Recipients The Essence of Yoga Drug Side Effects Calculator Iron Intake Calculator Daily Calorie Requirements Post-Nasal Drip Sanatogen Turmeric Powder - Health Benefits, Uses & Side Effects

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
ASK A DOCTOR ONLINE